Aldosterone-Producing Adenomas

Vitam Horm. 2019:109:407-431. doi: 10.1016/bs.vh.2018.10.007. Epub 2019 Jan 8.

Abstract

Aldosterone-producing adenomas (APA) are more common than initially anticipated. APA cause primary aldosteronism (PA), which affect 3-10% of the hypertensive population. Research during recent years has led to an increased knowledge of the background dysregulation of the increased aldosterone release, where mutation in the gene encoding the potassium channel GIRK4-KCNJ5-is the most common. Moreover, the discovery of aldosterone-producing cell clusters in apparently normal adenomas has also led to increased understanding of the development of PA, and presumably also APA. A continuum ranging from low-renin hypertension to APA and overt PA is reasoned, and the secondary effects of aldosterone on especially the cardiovascular system have also become more evident. Diagnostics of PA and APA is important in order to reduce cardiovascular morbidity and mortality, but the diagnostic methods are somewhat unspecific and insensitive, indicating the need for novel methods.

Keywords: Adrenal venous sampling; Aldosterone; Aldosterone-producing adenoma; Aldosterone-producing cell clusters; CYP11B2; Cortisol; Depolarization; Hypertension; KCNJ5; Low renin; Primary aldosteronism.

MeSH terms

  • Adrenal Cortex Neoplasms / metabolism*
  • Adrenal Cortex Neoplasms / pathology
  • Adrenal Cortex Neoplasms / therapy
  • Adrenocortical Adenoma / metabolism*
  • Adrenocortical Adenoma / pathology
  • Adrenocortical Adenoma / therapy
  • Aldosterone / metabolism*
  • Genetic Predisposition to Disease
  • Humans
  • Hyperaldosteronism / etiology*
  • Hyperaldosteronism / genetics
  • Hyperaldosteronism / metabolism
  • Hyperaldosteronism / therapy
  • Mutation

Substances

  • Aldosterone